Estrogen receptor-alpha (ER-α), which mediates the action of estradiol in fueling the development and progression of breast cancer, is expressed in approximately 70% of all malignant breast tumors, making estrogen receptor-positive (ER+) breast cancer the most common breast cancer subtype [1]. The gene discussed is ESR1; the disease is breast carcinoma.